baber/WOPTO huggingface dataset:
Patent AU-782644-B2 (AU)
Title: Composite sheet and process for making the same
Inventor: TANGE SATORU
IPC: B32B7/022
Filed: 2001-03-28
Granted: 2005-08-18
Abstract: This invention aims to provide a composite sheet having a layer of inelastically stretchable continuous fibers improved so that a possible unevenness in fiber diameter may be minimized. A composite sheet 10 comprises an elastically stretchable layer 3 and an inelastically stretchable layer 2 formed with inelastically stretchable continuous fibers 6 bonded to at least one surface of the elastically stretchable layer 2 intermittently in one direction. The continuous fibers 6 are oriented substantially in one direction thereof so that the composite sheet 10 may present a ratio S1/S2 of 3.0 or higher where S3 represents a tensile strength in this one direction and S2 represents a tensile strength in the direction orthogonal to this one direction. <IMAGE>
Patent AU-783036-B2 (AU)
Title: Nitrate esters and their use for neurological conditions
Inventor: THATCHER GREGORY R J
IPC: C07F9/09
Filed: 2000-03-15
Granted: 2005-09-15
Abstract: Compounds and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic compound comprising a nitrate ester, or a pharmaceutically acceptable salt or ester thereof.
Patent AU-701978-B2 (AU)
Title: Fibrinogen receptor antagonists and pharmaceutical preparation comprising the same
Inventor: HAYASHI YOSHIO
IPC: A61K31/495
Filed: 1997-06-27
Granted: 1999-02-11
Abstract: Compounds of the following general formula (I) and pharmaceutically acceptable salts thereof. <CHEM>   According to the present invention, compounds which antagonize the action of fibrinogen receptors and, therefore, have a high platelet aggregation-inhibiting activity, an in vivo stability against the cleavage with proteotytic enzymes and an excellent bioavailability are provided, which are useful as agents for inhibiting platelet aggregation. The pharmaceutical preparations comprising the compounds as active ingredient are very effective for preventing platelet thrombosis, thromboembolism and reocclusion during and after thrombolytic therapy, and preventing platelet thrombosis, thromboembolism and reocclusion after angioplasty of coronary and other arteries and after coronary artery bypass procedures. These preparations are also be very effective for preventing unstable angina and myocardial infraction, improving peripheral circulatory bloodstream and inhibiting blood coagulation during extracorporeal circulation.
Patent AU-766108-B2 (AU)
Title: Woven intravascular devices and methods for making the same and apparatus for delivery of the same
Inventor: HYODOH HIDEKI
IPC: D03D25/00
Filed: 2000-02-01
Granted: 2003-10-09
Abstract: Self-expandable, woven intravascular devices for use as stents for insertion and implantation into a variety of anatomical structures. The devices are formed from shape memory metals such as nitinol. The devices are formed from a single wire.
Patent AU-698225-B2 (AU)
Title: Alkyl-5-methylsulfonylbenzoylguanidin derivatives
Inventor: GERICKE ROLF DR
IPC: C07C317/46
Filed: 1995-10-13
Granted: 1998-10-29
Abstract: Benzoyl guanidine derivs. of formula (I) and their salts are new, R<1> = Me or Et; R<2> = H, 1-6C alkyl or alkenyl, 3-7C cycloalkyl, benzyl or Ph (opt. substd. by 1-3 Me, MeO, NH2, F, Cl, Br or CF3).
Patent AU-620406-B2 (AU)
Title: Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same
Inventor: SCHON ISTVAN
IPC: C07K5/068
Filed: 1989-06-13
Granted: 1992-02-20
Abstract: The invention relates to novel peptides comprising at least the amino acids Arg, Lys and Asp and optionally Val in that order wherein either (a) at least one of these is in the D-configuration, or (b) wherein Arg is bonded to the  xi -amino group of Lys or, (c) an Arg amino acid is bonded to the  alpha - and  xi -amino groups of Lys or (d) the Val is bonded to the  beta -carboxy group of the Asp, or any combination of the above options (a) to (d), and acid addition salts thereof and their preparations. The novel peptides are useful in the therapy of diseases where the decrease in the activity of the immune system is desirable.
Patent AU-760166-B2 (AU)
Title: A functional system for forming elastic rings into bunches for binding chickens, roasts and various meat products
Inventor: MIGNONE GIUSEPPE
IPC: A22C11/00
Filed: 2000-05-31
Granted: 2003-05-08
Abstract: A functional system for forming elastic rings (2) for binding chickens, roasts and various meat products, into bunches (7) wherein said elastic rings (2) are placed lightly tensioned between two rods (3), appropriately spaced; on said rods (3) said elastic rings (2) are pushed one near to the other in order to form two walls (4, 5); and one of these walls (4, 5) is bound by a strip (6) made of paper or other suitable material, having a different colour according to the kind of meat for which it is designed. It is evident that the choice of the different colours can be applied also to the elastic rings (2).  <IMAGE>
Patent AU-589352-B2 (AU)
Title: New derivatives of 1-dethia 2-thia cephalosporanic acid, process for preparing them and their preparation intermediates, their use as medicaments and the compositions containing them
Inventor: TEUTSCH JEAN-GEORGES
IPC: C07D513/04
Filed: 1985-02-13
Granted: 1989-10-12
Abstract: The following 1-dethia-2-thia-cephem cpds., within the scope of formula (I) of the parent patent, their internal salts and acid addn. salts are new: (1) 5-A-2-CF3-thiazolo (4,5-c)pyridinium (6S,7S,Z); A = (3-(7-(((2-amino-4-thiazolyl) (methoxyimino)acetyl) amino)-2-carboxy-8-oxo-4-thia-1- aza-bicyclo(4,2,0) -oct-2-en-3-yl)-2(E)-propenyl; (2) 7-(((2-amino-4-thiazolyl)(methoxy imino)acetyl)amino)-3-(3-(1,4-dihydro-3-formylamino -4-oxo-1-pyridyl)-1 (E).propenyl)8-oxo-4-thia -1-azabicyclo(4,2,O) -oct-2-ene-2-carboxylic acid (6S,7S,Z); (3) 5-8-thieno(3,2-c)pyridin ium (6S,7S, Z); B is as A but difluromethoxyimino replaces methoxyimino; (4) 5-B-4-methyl-thieno (3,2-c)pyridinium (6S,7S,Z); (5) 5-C-thiazolo (4,5-c)pyridinium(6S,7S, Z); C is as A but fluoromethoxyimino replaces methoxyimino; (6) 5-C-4-methyl-thieno (3,2-c)pyridinium (6S,7S,Z); (7) 5-C-thieno(3,2-c)pyridinium (6S,7S,Z); (8) 5-A-thiazolo (4,5-c)pyridinium(6S,7S, Z); (9) 5-A-2-methyl -1H-imidazolo(4,5-c) pyridinium(6S,7S,syn); (10) 5-A-2-phenyl-oxazolo(4,5-c) pyridinium(6S,7S,syn); (11) 5-A-2-ethyl-thiazolo(4,5-c) pyridinium(6S,7S,syn); (12) 5-B-thiazolo(4,5-c)pyridinium(6S, 7S,syn); (13) 2-amino-5-B-thiazolo(4,5-c) pyridinium(6S,7S,syn); (14) 7-c-thieno(2,3-b)pyridinium; (15) 1-A-1-(2-(5-nitro -1H-imidazol-1-yl) ethyl)pyrrolidinium(6S,7S,Z); (16) 7-(3-(7-(((5-amino -1,2,4-thiadiazol -3-yl)(methoxyimino)acetyl) amino)-2-carboxy-8-oxo -4-thia-1-azabi cyclo(4,2,0)oct-2 -en-3-yl)-2(E) - propenyl)thieno(2,3-b) pyridinium(6S,7S,syn); (17) (2,2-dimethyl -1-oxopropoxy)methyl 7-(((2-amino-thiazol-4-yl) (methoxyimino)acetyl) amino)-8-oxo-3-(3- ((1,3,4-thiadiazol-2-yl) thio)-1(E)-propenyl) -4-thia-1-azabi cyclo-(4,2,O) oct-2-en-2-carboxylate. -
Patent AU-738117-B2 (AU)
Title: Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K31/202
Filed: 1997-08-26
Granted: 2001-09-06
Abstract: This invention relates to the administration of arachidonic acid or docosahexaenoic acid or precursors thereof to children or pregnant women for the treatment or prevention of dyspraxia.
Patent AU-723378-B2 (AU)
Title: Dismantable facade scaffold
Inventor: SCHWORER ARTUR
IPC: E04G1/14
Filed: 1997-08-01
Granted: 2000-08-24
Abstract: A dismantlable, multi-story facade scaffold is formed of at least four vertical support elements and floor plates and railing elements which are mounted thereto. An additional scaffold story is erected by coupling an additional vertical support element to an already existing one and pivotally attaching one end of a railing element thereto at a location above where the floor plate for the next story will be placed. The other end of that railing element is pivotally attached to another vertical support element. This other vertical support element is then raised, thereby pivotally moving the rail element relative to the respective vertical support element until the rail element is in a horizontal position and the vertical support element is in the vertical position. The other vertical support element is now attached to the upper end of a corresponding vertical support of the lower scaffold story. Thereafter the floor plate for the additional scaffold story is installed so that a worker stepping on the floor plate of the higher story is protected from the very beginning against falling off. The connections between the ends of the railing and the respective vertical support elements are disengageable when they are in relatively inclined positions and become locked when the railing is perpendicular to the support elements. The scaffold is dismantled by reversing this procedure.
Patent AU-694307-B2 (AU)
Title: A receiver for spectrum analysis
Inventor: WECKSTROM MIKKO
IPC: G01R23/16
Filed: 1996-01-17
Granted: 1998-07-16
Abstract: PCT No. PCT/FI96/00037 Sec. 371 Date Sep. 18, 1997 Sec. 102(e) Date Sep. 18, 1997 PCT Filed Jan. 17, 1996 PCT Pub. No. WO96/22540 PCT Pub. Date Jul. 25, 1996A receiver for spectrum analysis includes at least one mixer in which a radio frequency input signal to be measured is mixed with an oscillator frequency generated by a voltage-controlled oscillator. In a detector, the level of an input signal to be measured is detected, after the signal has been transferred onto a lower frequency. The use of a logarithmic amplifier may be avoided by directing the detected signal to a decision means, which, in response to a change in the level of the detected input signal, provides a control voltage proportional to the magnitude and the direction of the change. The voltage commands an adjustable attenuator to attenuate the signal to be measured so that the level of the detected input signal substantially remains constant. The attenuation of the attenuator measured in decibels is linearly dependent on the control voltage, so that the values of the control signal directly represent the amplitude values.
Patent AU-672814-B2 (AU)
Title: Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
Inventor: STELLA VALENTINO J
IPC: A61K31/724
Filed: 1993-07-26
Granted: 1996-10-17
Abstract: Sulfoalkyl ether cyclodextrin derivatives and their use as solubilizing agents for water insoluble drugs for oral, intranasal, or parenteral administration are disclosed.
Patent AU-763915-B2 (AU)
Title: Stripping composition which can be used in particular in the construction and yachting field
Inventor: LALLIER JEAN-PIERRE
IPC: C11D7/50
Filed: 2001-05-24
Granted: 2003-08-07
Abstract: A coating removing composition (I) comprising at least one dibasic ester (a), at least one dipolar aprotic solvent (b), at least one inorganic filler having a thickening effect (c), water (d), at least one activator (e), at least one dispersant (f) and at least one cellulosic thickener (g).
Patent AU-762025-B2 (AU)
Title: Automatic speech recognition
Inventor: MERRILL JOHN
IPC: G10L15/26
Filed: 1999-06-17
Granted: 2003-06-19
Abstract: A system for responding to spoken commands enables a computer system to avoid some synchronization problems. In certain embodiments, object oriented programming may be utilized to create an object which seamlessly coordinates between an application program and a speech engine. An object may respond to a given command which is applied tactilely or through spoken commands in a fashion which allows the application to act in the same way whatever the form of the input. In this way, an application may efficiently utilize spoken commands. For example, the spoken commands may be recognized as applying to one of two currently active tasks or windows. Through coordination with the application itself, the speech engine can be advised of a sub-vocabulary within its overall vocabulary which should be consulted in connection with certain ongoing commands. This improves the accuracy of the speech recognition process, since the spoken words need only be compared to a smaller sub-vocabulary for speech recognition purposes.
Patent AU-674023-B2 (AU)
Title: Low flow rate nebulizer, method and apparatus
Inventor: RIGGS JOHN H
IPC: A61M11/06
Filed: 1993-08-10
Granted: 1996-12-05
Abstract: A nebulizer device, comprising: (a) a housing defining an interior volume therewithin, including a reservoir portion for holding medicament therein for entrainment into a carrier gas to form a delivery gas mixture comprising nebulized medicament and carrier gas; (b) a discharge port connected to the housing in flow communication with the interior volume therewithin, for discharging the delivery gas mixture from the housing; (c) a jet passage member having (i) an inlet portion for introduction of carrier gas thereinto and (ii) a nozzle portion positioned in the interior volume of the housing for discharging carrier gas in jet form in the interior volume, for entrainment of medicament from the reservoir portion of the housing in the carrier gas jet, such nozzle portion comprising a nozzle orifice accommodating carrier gas flow therethrough, wherein the nozzle orifice has an equivalent orifice diameter in the range of from about 0.005 inch to about 0.020 inch.
Patent AU-623771-B2 (AU)
Title: Process for 3-exomethylenecepham sulfoxide esters
Inventor: COPP JAMES DENSMORE
IPC: C07C/
Filed: 1990-05-15
Granted: 1992-05-21
Abstract: 3-Exomethylenecepham sulfoxide esters are obtained in improved yields via cyclization of 3-methyl-2-(4-chlorosulfinyl-2-oxo-3-acylamino-1-azetidinyl)-3-butenoic acid esters under anhydrous conditions with stannic chloride in the presence of both an oxo compound, e.g., an ether such as diethyl ether, a ketone such as acetone or methylethyl ketone, and an unsaturated compound, e.g., an alkene such as 1- or 2-hexene, a non-conjugated alkadiene such as 1,4-hexadiene, a cycloalkene such as cyclohexene, an allene, or a non-conjugated cycloalkadiene such as 1,4-cyclohexadiene.
Patent AU-675270-B2 (AU)
Title: Skin adhesive hydrogel, its preparation and uses
Inventor: LORENZ DONALD H
IPC: A61K47/30
Filed: 1993-12-06
Granted: 1997-01-30
Abstract: A skin adhesive hydrogel formed by mixing in aqueous medium: (A) major proportion of a high molecular weight water-soluble polyvinylpyrrolidone having ring opened pyrrolidone groups and (B) a minor proportion of a water-soluble multifunctional amine-containing polymer to form a water insoluble, water swellable cross-linked salt between carboxyl groups of the ring opened pyrrolidone groups and basic amine groups of the polyfunctional amine-containing polymer. The reaction is advantageously carried out in the presence of a plasticizer.
Patent AU-760677-B2 (AU)
Title: A method for producing a layered product
Inventor: OEELUND JAKOB
IPC: A61F13/00
Filed: 1999-09-27
Granted: 2003-05-22
Abstract: A method for production of a layered product including at least two layers, a first primary layer and second mouldable layer, wherein a continuous supply of a primary layer material and a supply of mouldable material are provided and wherein the primary layer material and the mouldable material are combined in moulding cavities, wherein the moulding cavities are placed in an endless loop, and the mouldable material and the primary layer are combined by placing the mouldable material on the primary layer about and/or in communication with the moulding cavities.
Patent AU-756391-B2 (AU)
Title: Application data table for a multiservice digital transmission system
Inventor: REY FRANCOIS
IPC: H04H20/00
Filed: 1999-09-24
Granted: 2003-01-09
Abstract: A method of transmission of application data 97 in a digital transport stream characterised in providing an application data table 110 containing information regarding the applications 97 carried in each service 91, 92 within the transport stream. The application data table 110 may conveniently be designated by a fixed PID value and a TID extension value varying in dependence on the bouquet of services chosen. The use of a single application data table to provide information across all services within a bouquet provides a number of advantages, in particular when deciding whether or not to maintain certain applications when switching between services. <IMAGE>
Patent AU-698467-B2 (AU)
Title: Thermally stable antistatic agents
Inventor: MONTE SALVATORE J
IPC: C08K5/057
Filed: 1996-04-30
Granted: 1998-10-29
Abstract: A process for rendering polymer compositions antistatic and the products of such process are described. The polymeric material is treated with a combination of selected trineoalkoxy amino zirconates and trineoalkoxy sulfonyl zirconates. These latter materials are soluble in the polyolefins, polyesters, polyamides, polyethers, polycarbonates, and polystyrenes and remain stable during the processing of these polymers. Furthermore, the antistatic agents of the invention are thermally stable to temperatures up to 825 DEG  F., do not "bloom" during the polymer processing, and are colorless, permanent, non-blooming and non-moisture dependent.
Patent AU-533793-B2 (AU)
Title: Antitumor protein hybrid
Inventor: MASUHO YASUHIKO
IPC: A61K47/48
Filed: 1980-07-16
Granted: 1983-12-08
Abstract: Antitumor protein hybrid, composed of a moiety which is substantially the fragment Fab of an antitumor immunogloblin and a moiety which is the subunit A of ricin, which is expressed bythe following formula (1):(where Fab indicates a moiety which is substantially the fragment Fab of an antitumor immunogloblin; RA indicates a moiety which is the subunit A of ricin; X indicates a divalent organic radical; S, and S<sub>2</sub> are both sulfur atoms, S<sub>1</sub> indicating a sulfur atom arising from the disulfide bond (-S-S- bond) in an immunoglobulin and S<sub>2</sub> a sulfur atom arising from the disulfide bond in ricin; n stands for 0 or 1 and m stands for an integer of 1 to 5). This antitumor protein hybrid has remarkable and specific cytotoxicity against tumor cells.
Patent AU-648718-B2 (AU)
Title: Apparatus and microbase for surface-enhanced raman spectroscopy system and method for producing same
Inventor: MILNE CHRISTOPHER GEORGE
IPC: G01J3/44
Filed: 1990-07-27
Granted: 1994-04-28
Abstract: A surface-enhanced Raman spectroscopy (SERS) assembly comprises a radiant energy source for directing a beam of radiant energy toward a target microbase. The target microbase includes a substrate, a roughened surface layer contiguously disposed on the substrate, and a sample-adsorption surface layer contiguously disposed on the first roughened layer. The sample-adsorption surface layer is effective to enhance a scattered Raman signal intensity for adsorbates adjacent the sample-adsorption surface layer by a factor of greater than 106 times. The sample-adsorption surface includes a plurality of submicron needles having a length of at least 3500 angstroms and a width of at least 500 angstroms. A method for manufacturing the target microbase comprises the steps of contiguously depositing on a substrate the first roughened layer having a deposited thickness of at least 1700 angstroms. A further metallic layer is then contiguously grown on the first roghened layer to form needles modeled as prolate spheroids having a length of at least 3500 angstroms and a width of at least 500 angstroms. In a specific embodiment, the needles are silver microneedles deposited from a vapor with a closed chamber and a vacuum pressure of at least 10-4 torr and at an evaporation rate from 2 to 20 angstroms per second. The silver microneedles are formed at a deposited thickness of at least 4000 angstroms as determined by a standard quartz thickness monitor.
Patent AU-764575-B2 (AU)
Title: Image processing apparatus, method therefor and recording medium storing image processing program
Inventor: MAEDA MITSURU
IPC: H04N7/26
Filed: 1999-12-02
Granted: 2003-08-21
Abstract: There is provided an image processing apparatus for entering image data encoded with plural encoding modes and security data for protecting the image data, discriminating, based on the security data, whether the reproduction of the encoded image data is permitted, judging the encoding mode of the encoded image data, and decoding the encoded image data according to the results of discrimination and judgment, a method therefor and a recording medium storing the corresponding image processing program. <IMAGE>
Patent AU-722523-B2 (AU)
Title: Muffler for internal combustion engines, especially in aviation, of improved geometry and material
Inventor: FERRI ALAIN
IPC: F01N1/24
Filed: 1996-07-16
Granted: 2000-08-03
Abstract: PCT No. PCT/FR96/01098 Sec. 371 Date Apr. 17, 1997 Sec. 102(e) Date Apr. 17, 1997 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/04220 PCT Pub. Date Feb. 6, 1997A muffler device for the exhaust of an internal combustion engine comprising a tube (1) formed of at least a cone and a cylinder of a single piece of perforated sheet metal with alternating holes of varying diameters distributed over its length, the tube (1) being surrounded with a coaxial envelope formed of a cylindrical and/or conical front portion (2) and a back portion (3) with a conical nozzle terminating in an exhaust pipe at an angle to permit exhaustion of gas, the exhaust gases passing through an annular space between the tube and envelope through outlet parts or walls whose form and geometry prevent the formation of a turbulence generating back pressure.
Patent AU-683260-B2 (AU)
Title: Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
Inventor: LIVEY IAN
IPC: C12R1/84
Filed: 1994-04-29
Granted: 1997-11-06
Abstract: An approach to Borrelia vaccine formulation taking into account serological, genotypic and epidemiological information by which OspC proteins from different strains of B. burgdorferi are grouped together. OspC antigens are chosen in order to constitute a representative sample of such groupings, so that the resulting vaccine provides the greatest cross-protectivity with the fewest number of antigens.
Patent AU-725311-B2 (AU)
Title: Device for limiting the bending radius of a flexible duct
Inventor: SECHER PHILIPPE
IPC: F16L35/00
Filed: 1998-02-25
Granted: 2000-10-12
Abstract: The invention concerns a device for limiting the bending radius of a flexible duct comprising at least a bend stiffener arranged around one length of the flexible duct and fixed by a rear part on a fixed end support, characterized in that it further comprises an element for maintaining the bend stiffener arranged between the flexible duct and the bend stiffener and comprising at least a portion capable of flexural bending extending over one length of the flexible duct located at least between the rear part and the end of the bend stiffener.